KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Basic) (2016 - 2025)

Merck (MRK) has disclosed EPS (Basic) for 17 consecutive years, with $1.21 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 18.24% to $1.21 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 through Dec 2025, up 7.99% year-over-year, with the annual reading at $7.3 for FY2025, 7.99% up from the prior year.
  • EPS (Basic) for Q4 2025 was $1.21 at Merck, down from $2.32 in the prior quarter.
  • The five-year high for EPS (Basic) was $2.32 in Q3 2025, with the low at -$2.35 in Q2 2023.
  • Average EPS (Basic) over 5 years is $1.23, with a median of $1.38 recorded in 2024.
  • The sharpest move saw EPS (Basic) plummeted 250.64% in 2023, then soared 402.04% in 2024.
  • Over 5 years, EPS (Basic) stood at $1.21 in 2021, then decreased by 2.48% to $1.18 in 2022, then crashed by 141.53% to -$0.49 in 2023, then skyrocketed by 402.04% to $1.48 in 2024, then dropped by 18.24% to $1.21 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $1.21, $2.32, and $1.76 for Q4 2025, Q3 2025, and Q2 2025 respectively.